Not saying this will happen but looking historically over the entire chart since listing it's worth looking at how far the indicators stretched, obviously it was a bit to far to soon as is often the case with biotechs moving on market anticipation of their objectives well ahead of time as they eye the eventual goal long before the business has actually been advanced then loose interest when the true time frames come into the picture. But know here we are 5 years down the track with many of these beginning to materialise especially of the remainder of the year so i thought it was worth posting for forward possibilites.
Alot of signifcant news to be released over the coming 6 months that could validate such moves Phenomica spin off, 3 Big Pharma deals to be finalised, AstraZeneca/Pfizer to complete stage 1 and put forward there objectives, Roche to finalise intracellular / blood-brain barrier & potentially move to full license agreement.
PYC Price at posting:
7.6¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)